ERBB2 and breast cancer: Based on the above findings, we further demonstrated that the interference with circ-ERBB2 repressed HER2-positive breast cancer cell proliferation, invasion, migration and accelerated cell apoptosis via the miR-136-5p/TFAP2C axis or the miR-198/TFAP2C axis through the rescue assays.